提供者:上海雅吉生物科技有限公司 发布时间:2026/10/9 8:54:31 阅读次数:63次 进入该公司店铺
文章标题:Salinomycin inhibits orthopoxvirus infection in vitro in vivo by blocking endosomal acidification
作者列表:Wang Xiang, Luo Kai, Bai He, Zhang Xudong, Qu Jialin, Wang Xiaoqing, Sun Xu, Zhao Yuting, Wang Bin, Zhang Guixin
影响因子:3.9
期刊:Scientific Reports
发表时间:2026-4-24
DOI:10.1038/s41598-026-49458-3
文献主题:Abstract
Intrahepatic cholangiocarcinoma (ICC) is a highly aggressive liver malignancy with rising global incidence poor prognosis. Despite recent advances in treatment strategies, effective therapeutic options for ICC remain limited. Solamargine (SM), a natural steroidal alkaloid, has demonstrated anticancer activity, yet its mechanisms in ICC are fully understood. This study shows that SM inhibits ICC progression by inducing both apoptosis ferroptosis in vitro in vivo. SM significantly suppressed proliferation, migration, invasion of ICC cells (HUCCT-1 HCCC-9810), with minimal cytotoxicity toward normal biliary epithelial cells (HIBEC). Mechanistically, SM induced mitochondrial dysfunction, ROS accumulation, lipid peroxidation, leading to apoptosis ferroptosis. Transcriptome sequencing gene set enrichment analysis (GSEA) revealed that SM treatment activated apoptosis- ferroptosis-related pathways, including MAPK signaling. Western blot analysis pharmacological inhibition assays confirmed that p38 MAPK activation was essential for SM-induced cell death, with ROS acting as an upstream activator. In vivo, SM significantly inhibited tumor growth in both orthotopic subcutaneous ICC mouse models showed better tolerability than gemcitabine. Tumor tissue analysis further confirmed increased markers of apoptosis ferroptosis, along with p38 MAPK activation. These findings suggest that SM exerts dual antitumor effects in ICC, which are associated with the induction of apoptosis ferroptosis may involve the ROS/p38 MAPK signaling axis, highlighting its potential as a therapeutic cidate for ICC.
① 凡本网注明"来源:阿仪网"的所有作品,版权均属于阿仪网,未经本网授权不得转载、摘编或利 用其它方式使用。已获本网授 权的作品,应在授权范围内使用,并注明"来源:阿仪网"。违者本网将追究相关法律责任。
② 本信息由注册会员:上海雅吉生物科技有限公司发布并且负责版权等法律责任。
版权声明